Few & Far Between: Conversations from the Front Lines of Drug Development
Chris O'Brien
35 episodes
8 hours ago
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
All content for Few & Far Between: Conversations from the Front Lines of Drug Development is the property of Chris O'Brien and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®
Few & Far Between: Conversations from the Front Lines of Drug Development
38 minutes 46 seconds
4 months ago
Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®
How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks of running studies in this region.
In our latest episode of the Biorasi Few & Far Between podcast, host Chris O'Brien welcomes Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®. Tune in as we spotlight the advantages of running studies in #LATAM - from data quality to speed to approval.
Few & Far Between: Conversations from the Front Lines of Drug Development
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
